RecruitingACTRN12610000989044

Trial of an injection to reduce shoulder pain for people with Motor Neurone Disease

Suprascapular nerve block for the treatment of shoulder pain in patients with Motor Neurone Disease (MND)


Sponsor

Repatriation General Hospital

Enrollment

80 participants

Start Date

Mar 12, 2010

Study Type

Interventional

Conditions

Summary

Chronic shoulder pain is a common and distressing symptom for a large number of people with motor neurone disease. Treatments which are sometimes used for this problem include physiotherapy, pain killers and injections into the shoulder. Unfortunately, despite these treatments the pain frequently is not well controlled. Recently, a number of rheumatologists around the world have been using an injection to numb the nerve that supplies pain fibres to the shoulder in. This nerve is the suprascapular nerve. The results of studies to date have proven that this form of therapy is safe and works effectively to reduce pain and improve function. However, more information is required to establish this as a useful additional treatment in people with MND. Researchers at the Repatriation Hospital (Dr Michael Shanahan, Dr Peter Allcroft and Karen Glaetzer) are studying this treatment to see whether it is effective in reducing pain in people with motor neurone disease. In order to establish whether the treatment is effective in this group, we are performing a trial where we inject around the nerve at a point just above the shoulder blade with a mixture of local anaesthetic and anti-inflammatory steroid and then assess whether this helps to reduce the pain. We then compare the result of the injection with a group of people who do not receive the active injection, but rather a placebo injection of sterile normal saline (salt water). Placebo injections are an accepted practice to ascertain if the improvement in pain is due to the medication used or just the process of injecting into the nerve. We are inviting you to be involved


Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

This study is looking at whether a nerve block injection above the shoulder blade (called a suprascapular nerve block) can reduce chronic shoulder pain in people with motor neurone disease (MND). Participants will receive either a real injection (local anesthetic and steroid) or a placebo (salt water) injection, and researchers will measure how much the pain improves over 12 weeks. You may be eligible if: - You have been diagnosed with motor neurone disease (MND) - You have chronic shoulder pain You may NOT be eligible if: - Your life expectancy is less than 12 weeks (the follow-up period) - You are already in significant difficulty breathing (severe respiratory distress) Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A single injection of 10mls of 0.5% bupivocaine and 40 mg of depomedrol into the suprascapular fossa.

A single injection of 10mls of 0.5% bupivocaine and 40 mg of depomedrol into the suprascapular fossa.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000989044


Related Trials